Here is the most counterintuitive fact in red light therapy: past a certain point, more light does less. Not more benefit at a slower rate. Less. Longer sessions and stronger output do not stack up into better results, and beyond the sweet spot they can quietly work against you. Scientists have a name for this pattern, the biphasic dose response, and it is one of the most established findings in the field.
If you have ever assumed that if ten minutes is good, thirty must be better, this is the article that saves you the wasted time. The right dose beats the biggest dose, every time. Understanding why is what separates using a device well from just pointing it at your face and hoping.
What the biphasic dose response actually means
The biphasic dose response describes a simple but stubborn rule: low doses of light stimulate your cells, medium doses do less, and high doses can suppress the very activity you were trying to encourage. Plotted on a graph, the benefit rises to a peak and then falls back down. Scientists often call this the Arndt-Schulz curve.
This is not a fringe idea. Two landmark reviews of low-level light therapy documented the biphasic pattern across cell studies and animal experiments, showing that low levels of light stimulate and repair tissue more effectively than higher levels [1][2]. A 2023 review of photobiomodulation for inflammation described the same curve in plain terms: small doses stimulate, medium doses inhibit, and very large doses can damage [3]. The effect is real, repeatable, and central to why some studies of light therapy succeed while others fail.
Why your cells respond this way
The reason lives in the mitochondria, the energy engines inside your cells. Red and near-infrared light are absorbed there, nudging up energy production and releasing small bursts of signaling molecules called reactive oxygen species.
At low doses, those molecules act as helpful messengers, switching on repair, collagen production, and healthy cell activity. At high doses, the same molecules flip character and become stressful, even cytotoxic. Researchers describe reactive oxygen species as having a "Janus" nature: beneficial in small amounts, harmful in large ones [2]. That single mechanism explains the whole curve. A little light sends a helpful signal. Too much light sends a stress signal. Your cells cannot tell the difference between "generous" and "excessive," they simply respond to the dose they receive.
Where the sweet spot sits
Dose in light therapy is measured in joules per square centimeter, written J/cm². It combines how strong the light is with how long you are exposed. And the useful range is narrower than most people expect.
The research points to a low, specific window. Below roughly 2 to 3 J/cm², the response is often too weak to matter. For skin cells specifically, some of the strongest results in the literature cluster low, with one frequently cited fibroblast study finding optimal collagen-building activity around 5 J/cm² of red light [3]. A practical target for skin sits in the range of about 3 to 6 J/cm². Push far beyond the effective window and you cross into the flat or inhibitory part of the curve, where extra minutes stop adding benefit and can start subtracting it.
The takeaway is not a number to memorize. It is a mindset: the goal is the correct dose, not the maximum one.
Why this makes device design and protocol matter
This is exactly why a device cannot just be "bright" and call it a day. If dose is the thing that determines results, then output, distance, and time all have to be considered together, and a good protocol is not a limitation. It is the whole point.
A device that encourages endless marathon sessions is not being generous, it is ignoring the science. INFERA's approach is built the other way around: defined wavelengths at 625nm red and 850nm near-infrared, a consistent 42°C glass applicator that keeps delivery steady and close, and recommended session lengths designed to land you in the effective range rather than blow past it. The protocols exist because the biphasic curve exists. Following them is how you stay on the productive side of the peak.
More is not devotion. Correct is devotion. A device that respects the dose is doing you a bigger favor than one that lets you overdo it.
Frequently Asked Questions
Can you overdo red light therapy?
Yes, in the sense that more is not better. The biphasic dose response means that beyond an effective window, additional light stops adding benefit and can begin to suppress the cellular activity you want [1][2]. This rarely causes harm in the way a sunburn would, but longer or more frequent sessions past the sweet spot tend to waste time rather than improve results.
How much red light therapy is optimal?
Dose is measured in J/cm², combining intensity and time. Research suggests a relatively low, specific window is most effective, with strong results for skin cells clustering around a few J/cm², often in the range of about 3 to 6 J/cm² [3]. The practical implication is to follow your device's recommended session length rather than extending it.
Is longer red light therapy better?
No. Longer sessions do not linearly improve outcomes and can push you past the peak of the biphasic dose response into the flat or inhibitory zone [1][2]. Consistency over weeks matters far more than the length of any single session. A well-designed protocol targets the effective dose, not the longest possible exposure.
What is the biphasic dose response in red light therapy?
It is the scientific pattern, also called the Arndt-Schulz curve, describing how low doses of light stimulate cells, medium doses do less, and high doses can inhibit or stress them [1][3]. It is one of the most established principles in photobiomodulation and the reason dosing precision matters more than raw power.
Why does more light stop working?
Red and near-infrared light stimulate cells partly by releasing reactive oxygen species, which act as helpful signals at low doses but become stressful or cytotoxic at high doses [2]. Because the same mechanism helps and harms depending on amount, exceeding the effective dose flips the signal from beneficial to counterproductive.
The right dose beats the biggest dose
Red light therapy rewards precision, not enthusiasm. The biphasic dose response means there is a genuine sweet spot, a low and specific window where light stimulates repair and collagen, and a threshold past which more light simply does less. Knowing this changes how you use a device: you stop chasing longer sessions and start trusting the dose. That is the logic INFERA's wavelengths, thermal delivery, and recommended protocols are built around. To see how it works in practice, explore the INFERA device and its protocols →
Â
Sources
- Huang YY, et al. Biphasic Dose Response in Low Level Light Therapy. Dose-Response, 2009.
- Huang YY, et al. Biphasic Dose Response in Low Level Light Therapy – an Update. Dose-Response, 2011.
- Nie F, et al. Biphasic dose response in the anti-inflammation experiment of PBM. Lasers in Medical Science, 2023.